MEDIA FEATURE

Wes Cowen on Why Benefits Cost Management Can’t Wait for Open Enrollment

OneDigital’s benefits leader on specialty drugs, GLP-1 demand, and 2027 strategy in an expert interview with Insurance Business.

Author

Article Summary

In an exclusive interview with Insurance Business America, OneDigital’s Wes Cowen, National Practice Leader for Employee Benefits, explains how specialty drug costs, GLP-1 demand, and growing plan complexity are shaping the toughest renewal cycle in years, and why employers should treat benefits cost management as a year-round discipline.

NYC Think Tank Wes

Employers and brokers are heading into one of the toughest renewal cycles the group benefits industry has seen. In an interview with Insurance Business as part of its series on open enrollment takeaways and the outlook for 2027, Wes Cowen, National Practice Leader for Employee Benefits at OneDigital, explains why cost management has to be a year-round discipline and how OneDigital is helping employers prepare.

“The last two years have been among the most challenging of my career, and employers feel it. The best way to meet that pressure is to plan all year, so that open enrollment becomes the culmination of the work rather than the starting point. The strongest clients are already looking ahead to 2028 while their 2027 enrollment is still underway.”

— Wes Cowen, National Practice Leader, Employee Benefits, OneDigital

With 25 years in the industry, including 15 at two large national carriers before moving into consulting, Cowen says OneDigital spent much of the past 12 months helping employers get ready for this cycle.

What Cowen sees ahead:

  • There is no one-size-fits-all strategy. Funding conversations now span fully insured, level-funded, self-funded, and emerging structures such as ICHRAs, alongside PBM transparency reviews, narrow pharmacy and provider networks, and site-of-care shifts for high-cost services like infusion therapy. Cowen’s team tailors strategy to each employer’s population, risk profile, and local market.
  • Specialty pharmacy is the defining cost driver. Growing demand for GLP-1 medications adds to the pressure. Rather than choosing between full coverage and exclusion, Cowen advises structured frameworks built on clinical criteria, quantity limits, and utilization management.
  • Continuous risk analysis is replacing the annual claims snapshot. OneDigital’s Impact Studio gives advisors and employers ongoing population risk analysis, so emerging cost drivers can be spotted and addressed sooner.
  • Technology informs advisors; it doesn’t replace them. Cowen emphasizes that data analysis is still delivered by a human advisor.
  • Complexity raises the value of expert guidance. Cowen expects subject matter expertise to matter more as employers sort through their options.

“Technology can analyze data around the clock and flag emerging risk, but it’s the advisor who turns those insights into action. In a system this complex, expert consultation is more valuable to employers than it has ever been.”

Cowen closed on a note of measured optimism, hoping that bipartisan attention to the healthcare cost crisis, particularly pharmacy pricing, could bring meaningful relief to employers in the year ahead.

Read the full article on Insurance Business here: Open enrollment: benefits brokers face the hardest renewal cycle yet

Publish Date:Nov 20, 2026Categories:Employee Benefits, News